Home › Mologic Gets CE Mark for Infection Dx

Mologic Gets CE Mark for Infection Dx

Jun 14, 2017

NEW YORK (360Dx) – British diagnostics firm Mologic today said that it has received CE marking for its Periplex point-of-care test for detection of infections in patients undergoing peritoneal dialysis.

The company said that it also has launched the test.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Jun
05
Featured Webinar

Text Mining at Sanofi for Genotype-Phenotype Associations in Multiple Sclerosis

This webinar will discuss how Sanofi used literature mining to annotate the association of human leukocyte antigen (HLA) alleles with diseases and drug hypersensitivity as part of a multiple sclerosis (MS) biomarker discovery project.

Jun
19
Featured Webinar

RNA in situ Hybridization: The Next Generation of Immunohistochemistry?

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.

What's Popular?

In Infectious Disease

  1. Procalcitonin Assay Produces Few Changes in Antibiotic Use, Study Finds

  2. IncellDx Gets CE Mark for HPV Assay

  3. Dutch Researchers Develop Multiplex RT-PCR Assay to Detect Bloodstream Infections

    Premium

  4. WHO Releases First Essential List for IVD Tests

  5. MeMed Study Indicates ImmunoXpert Outperforms Existing Infectious Disease Tests

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.